Chronic viral hepatitis and primary liver cancer in the republic of Sakha (Yakutia)
https://doi.org/10.22625/2072-6732-2019-11-4-79-84
Abstract
Study objective: identification of risk factors for the formation of cirrhosis and PLC in patients with chronic hepatitis B, C and D to develop a personalized, approach in treatment and prevention, of complications.
Materials and. methods. The materials of the official statistics of the Office of Rospotrebnadzor in the Republic of Sakha (Yakutia), the infectious disease department for treating patients with viral hepatitis of the Yakutsk Clinical Hospital were studied. Complex clinical, serological, and. molecular biological studies with the genotyping of hepatitis B, C, and D viruses were conducted (n = 354).
The results of the study. The prevalence of CVH B, C and. D in the territory of Yakutia is the primary cause of high, complications (such, as cirrhosis and. PLC) rate.
The most significant risk factors for the formation of cirrhosis and. PLC in CVH among the population, living in various geographical areas of the republic are identified. Large-scale vaccination, against hepatitis B will not only significantly reduce the amount of deaths caused, by HBV infection, but also generally have a positive effect on the epidemiological situation in the region. The organizational model for assisting CVH patients in the Republic of Sakha (Yakutia) has been developed.
Findings. Regions with the highest prevalence of hepatitis B, C and. D with the progressive course of the disease are identified. Risk factors for PLC in hepatitis B, C and. D are isolated.
About the Authors
S. S. SleptsovaRussian Federation
Yakutsk
Competing Interests: not
S. S. Sleptsov
Russian Federation
Competing Interests: not
M. N. Andreev
Russian Federation
Yakutsk
Competing Interests: not
M. E. Ignatieva
Russian Federation
Yakutsk
Competing Interests: not
L. I. Budatsyrenova
Russian Federation
Yakutsk
Competing Interests: not
References
1. Sleptsov, S.S. Aeroport Oymyakon — istoriya i sud'by / S. S. Sleptsov. — 2-e izd., pererab. i dop. — Yakutsk: Media-kholding Yakutiya, 2019. — 408 s.
2. Alekseeva, M.N. Virusnye gepatity v Respublike Sakha (Yakutiya): dis. ... d-ra med nauk: 14.00.10 / Alekseeva Marfa Nikolaevna. — SPb, 2002. — 285 s.
3. Petrova, P.G. Ekologo-fiziologicheskie aspekty adaptat-sii cheloveka k usloviyam Severa / P.G. Petrova. — Yakutsk: Dani AlmaS, 2011. — 272 s.
4. Sleptsova, S.S. Virusnye gepatity V i D kak osnovnye fak-tory formirovaniya tsirroza i pervichnogo raka pecheni v Re-spublike Sakha (Yakutiya) / S.S. Sleptsova, A.G. Rakhmanova, T.T. Bugaeva //VICh-infektsiya i immunosupressii, 2012, Tom 4, № 2. — Sankt-Peterburg, 2012. — S.109-116.
5. Bremya virusnykh gepatitov v Rossiyskoy Federatsii i puti ego snizheniya v dolgosrochnoy perspektive (na primere gepa-tita S) / N.D. Yushchuk i soavt. // Terapevticheskiy arkhiv 12 — 2013. — S. 79-85.
6. Abdurakhmanov D.T. Khronicheskiy gepatit V i D. — M.: GEOTAR-Media, 2010.- 288 s.
7. Gepatologiya Severa / P.M. Ivanov [i dr.]. — Yakutsk: Sfera, 2012. — 304 s.
8. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. available at: /en/http://www.who.int/hepa-titis/publications/globalhepatitis-report2017.
9. Fedeli U., Grande E., Grippo F., Frova L. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data. World J Gastroenterol. 2017; 23 (10): 1866 — 71. doi: 10.3748/wjg.v23.i10.1866.
10. Yushchuk, N.D. Bremya smertnosti ot virusnykh gepatitov V i S: metodologiya otsenki i pokazateli v Moskve v 2015 — 2017 gg. / Yushchuk N.D., Zayrat'yants O.V., Znoyko O.O. i soavt. // Infektsionnye bolezni: novosti, mneniya, obuchenie, 2018, tom 7, № 4. — Moskva, 2018. — S. 8-14.
11. Parenteral'nye virusnye gepatity i ikh iskhody v Respub-like Sakha (Yakutiya) / Sleptsova S.S. — M., 2017. — 208 s.: il.
12. Ivaniushina, V. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia /V. Ivaniushi-na, N. Radjef, M. Alexeeva et. al. //J. Gen. Virol. — 2000. — Vol.82 — Pt. II. — P. 2709-2718.
13. European Association for the Study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J.Hepatol 2018;69: 182-236.
Review
For citations:
Sleptsova S.S., Sleptsov S.S., Andreev M.N., Ignatieva M.E., Budatsyrenova L.I. Chronic viral hepatitis and primary liver cancer in the republic of Sakha (Yakutia). Journal Infectology. 2019;11(4):79-84. (In Russ.) https://doi.org/10.22625/2072-6732-2019-11-4-79-84